News & Events about Pear Therapeutics Inc.
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today the expansion of its collaboration with BrightView Health, an addiction treatment provider that offers evidence-based...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the inclusion of its PDTs reSET and reSET-O on the January 2023 Florida Medicaid Preferred Drug List (PDL). reSET and...
The California Department of Health Care Services (DHCS) has selected Pear Therapeutics, Inc. (Nasdaq: PEAR), a leader in developing and commercializing software-based medicines, to support the implementation of the Recovery Incentives: Californias Contingency Management Program. Contingency...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization specializing in local...
Business Wire
2 months ago
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey...